Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040124 | SCV000063815 | likely benign | not specified | 2018-08-16 | criteria provided, single submitter | clinical testing | c.28030+5_28030+7delGCC in intron 118 of TTN: This variant is not expected to ha ve clinical significance because it has been identified in 0.04% (10/25696) of F innish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.bro adinstitute.org; dbSNP rs397517538). In addition, this variant is located in the 5' splice region and computational tools do not suggest an impact to splicing. ACMG/AMP Criteria applied: BS1; BP4. |
Labcorp Genetics |
RCV000459619 | SCV000542245 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-01-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000040124 | SCV000565638 | benign | not specified | 2015-10-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000714012 | SCV000844675 | uncertain significance | not provided | 2017-10-09 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000714012 | SCV000855270 | uncertain significance | not provided | 2017-11-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000714012 | SCV001152992 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4 |
Diagnostic Laboratory, |
RCV000714012 | SCV001742672 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000714012 | SCV001920584 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000714012 | SCV001959378 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004734560 | SCV005353803 | likely benign | TTN-related disorder | 2024-04-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |